NasdaqCM - Delayed Quote USD

Femasys Inc. (FEMY)

1.3300 0.0000 (0.00%)
At close: April 24 at 4:00 PM EDT
1.3300 0.00 (0.00%)
After hours: April 24 at 4:24 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,071.9700
1,071.9700
1,206.2180
1,179.6890
1,037.9180
Cost of Revenue
380.0690
380.0690
441.9380
370.3840
306.5330
Gross Profit
691.9010
691.9010
764.2800
809.3050
731.3850
Operating Expense
15,200.3160
15,200.3160
12,364.5440
9,146.1090
7,664.5280
Operating Income
-14,508.4150
-14,508.4150
-11,600.2640
-8,336.8040
-6,933.1430
Net Non Operating Interest Income Expense
265.6290
265.6290
214.7000
-15.4580
9.9510
Other Income Expense
--
--
-2.3060
818.4170
10.0000
Pretax Income
-14,242.7860
-14,242.7860
-11,387.8700
-7,533.8450
-6,913.1920
Tax Provision
4.3380
4.3380
6.3000
4.0000
1.8000
Net Income Common Stockholders
-14,247.1240
-14,247.1240
-11,394.1700
-7,537.8450
-6,914.9920
Diluted NI Available to Com Stockholders
-14,247.1240
-14,247.1240
-11,394.1700
-7,537.8450
-6,914.9920
Basic EPS
-0.93
--
-0.96
-1.12
-0.76
Diluted EPS
-0.93
--
-0.96
-1.12
-0.76
Basic Average Shares
15,384.3760
--
11,815.0190
6,712.0280
9,111.5510
Diluted Average Shares
15,384.3760
--
11,815.0190
6,712.0280
9,111.5510
Total Operating Income as Reported
-14,508.4150
-14,508.4150
-11,600.2640
-8,336.8040
-6,933.1430
Total Expenses
15,580.3850
15,580.3850
12,806.4820
9,516.4930
7,971.0610
Net Income from Continuing & Discontinued Operation
-14,247.1240
-14,247.1240
-11,394.1700
-7,537.8450
-6,914.9920
Normalized Income
-14,247.1240
-14,247.1240
-11,394.1700
-7,537.8450
-6,914.9920
Interest Income
431.0190
431.0190
228.1640
3.7680
22.5040
Interest Expense
165.3900
165.3900
13.4640
19.2260
12.5530
Net Interest Income
265.6290
265.6290
214.7000
-15.4580
9.9510
EBIT
-14,077.3960
-14,077.3960
-11,374.4060
-7,514.6190
-6,900.6390
EBITDA
-13,169.4110
-13,169.4110
-10,485.2660
-6,550.3320
-5,799.8750
Reconciled Cost of Revenue
380.0690
380.0690
114.0310
370.3840
306.5330
Reconciled Depreciation
907.9850
907.9850
889.1400
964.2870
1,100.7640
Net Income from Continuing Operation Net Minority Interest
-14,247.1240
-14,247.1240
-11,394.1700
-7,537.8450
-6,914.9920
Normalized EBITDA
-13,169.4110
-13,169.4110
-10,485.2660
-6,550.3320
-5,799.8750
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
12/31/2020 - 6/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZJYL Jin Medical International Ltd.
3.5300
+0.86%
 
NEPH Nephros, Inc.
2.1900
+3.79%
 
SMTI Sanara MedTech Inc.
32.50
-0.31%
 
MBOT Microbot Medical Inc.
0.8910
+1.26%
 
NSTGQ NanoString Technologies, Inc.
0.3000
0.00%
 
GCTK GlucoTrack, Inc.
0.4790
-36.97%
 
QLINEA.ST Q-linea AB (publ)
2.0100
+0.50%
 
CSSI Costas, Inc.
0.0340
0.00%
 
S2M.ST S2Medical AB (publ)
0.0947
-5.30%
 
SAUHY Straumann Holding AG
15.20
+1.13%